← Leaderboards
Sarah Ann Carratt
Oregon Health & Science University
$195,098
Attributed
$195,098
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $68.6K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$195,098 · 1
By mechanism
F32$195,098 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Julia E Maxson$5,322,132
- Jeffrey Wallace Tyner$13,872,769
- Theodore Paul Braun$2,536,053
- Bill H Chang$918,328
- Haijiao Zhang$1,696,427
Others in their field
Other Emerging Leaders on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$211,662,224
Research focus
BaseBindingBinding ProteinsBiologicalBiologyBone MarrowBone Marrow TransplantationCancer BiologyCell CycleCell Cycle ProgressionCell Cycle ProteinsCell Cycle RegulationCell LineCell ProliferationChronic Myelomonocytic LeukemiaChronic Neutrophilic LeukemiaClinically RelevantClinical PhenotypeColony-Forming Units AssayComplexCsf3r GeneDisease ModelDna BindingAt-Hook Motifs
Grant awards (3)
Determining the biological importance of SETBP1 functional domains to develop novel therapeutic approaches for myeloid leukemias$68,562
F32 · FY2021 · CA · contact PI
Determining the biological importance of SETBP1 functional domains to develop novel therapeutic approaches for myeloid leukemias$65,310
F32 · FY2020 · CA · contact PI
Determining the biological importance of SETBP1 functional domains to develop novel therapeutic approaches for myeloid leukemias$61,226
F32 · FY2019 · CA · contact PI